Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glycyrrhiza inflata extract is a plant-derived extract obtained from the roots of Glycyrrhiza inflata (a species of licorice). A specialized formulation of this extract, known as AD-lico/Healthy Gut, is under clinical development by ADbiotech for the treatment of gastrointestinal diseases and inflammatory bowel disease. The extract contains key bioactive components such as licochalcone A, liquiritigenin, licochalcone E, glycyrrhizin, and glabridin. It has been shown to exhibit anti-inflammatory, gastroprotective, and gastric-relaxing effects, including the reduction of inflammatory markers like iNOS and COX-2, and the inhibition of Helicobacter pylori mucosal damage. The formulation is specifically prepared to minimize glycyrrhizin levels, thereby reducing potential side effects such as hypokalemia and muscle weakness. Additionally, components of the extract have demonstrated potential in suppressing aromatase expression and activity, suggesting a role in breast cancer chemoprevention [2566].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycyrrhiza inflata extract.